Patient | Sex (w/m) | Genetic mutation | Age at diagnosis (years) | Period of CVC use (age in years) | Cumulative months of CVC use | Age at follow-up (years) | Venous access at follow-up |
---|---|---|---|---|---|---|---|
1 | w | LDLR homozygous | 3 | 5 to 7 | 24 | 8 | peripheral |
2 | w | LDLR homozygous | 2 | 4 to 6 | 23 | 7 | peripheral |
3 | w | LDLR homozygous | 2 | 5 to 7 | 30 | 8 | peripheral |
4 | m | LDLR homozygous | 1 | 3 to 5 | 8 | 7 | AVF |